Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFeedback Regulatory News (FDBK)

Share Price Information for Feedback (FDBK)

Share Price is delayed by 15 minutes
Get Live Data
6.75    0.00 (0.00%)
Bid:
6.70
Ask:
6.80
Spread: 0.10 (1.493%)
Market Cap: £2.96m
FDBK Live PriceLast checked at - London Stock Exchange

Intraday Feedback Share Chart

Issue of Equity

2 Mar 2007 14:31

Feedback PLC02 March 2007 Feedback plc ("the Company") Issue of Equity and Compulsory Conversion of Preference Shares Feedback PLC announces that yesterday it received conversion notices fromcertain holders of the Company's 10 per cent. (net) convertible redeemablecumulative preference shares of Β£1 ("Preference Shares") to convert, inaggregate 405,719 Preference Shares having a nominal paid up value of Β£543,405into 2,717,025 ordinary shares of 10p each in the Company ("Ordinary Shares").Further details regarding the Preference Share holders who have converted theirPreference Shares are set out below. Pursuant to a block listing, granted on 28 November 2006, 2,468,329 OrdinaryShares have been admitted to AIM. An application has been made for a further248,696 Ordinary Shares to be admitted to AIM and it is anticipated that theshares will be admitted to trading on AIM with effect from Thursday 8 March2007. Following this conversion of Preference Shares, there will be 15,099,196Ordinary Shares in issue and 365,095 Preference Shares. Furthermore, as aconsequence of these conversions, 75 per cent. of the holders of PreferenceShares have now exercised their right to convert their Preference Shares intoOrdinary Shares. Pursuant to the Articles of Association of the Company, theCompany has given four weeks notice to require all holders of Preference Shareswhich have not converted to compulsorily convert, from the expiry of suchnotice, the whole of their holding of Preference Shares into new OrdinaryShares. The basis of conversion is 5 ordinary shares for every Β£1 in nominal amount ofpreference shares. Arrears of dividend due to holders of Preference Shares isconverted on the same basis so that 5 ordinary shares will be issued for everyΒ£1 of arrears of dividend. The notice will expire on 30 March 2007 at whichtime the remaining Preference Shares will be converted into Ordinary Shares. Although the Ordinary Shares to be issued on conversion will not rank for anydividend in respect of the year ended 31 March 2007, they will rank pari passuin all other respects with the existing Ordinary Shares. Preference Sharesconverted in 2007 will not rank for Preference Share dividends after conversion. Assuming no further conversions during the notice period, the remaining 365,095Preference Shares having a nominal paid up value of Β£502,529 will convert into2,512,645 new Ordinary Shares and there will then be 17,611,841 Ordinary Sharesin issue. Application has been made to AIM and it is anticipated that admission of the2,512,645 new Ordinary Shares, arising upon compulsory conversion, to trading onAIM will become effective and that dealings will commence on Monday 2 April. Changes in interests As referred to above, the Company yesterday received conversion notice fromcertain Preference Share holders, as detailed below: 1. In their capacity as trustees of the Blackman Will Settlement, DavidHarding, Chairman, and John Westcott, a non-executive director, converted235,405 Preference Shares with a nominal paid up value of Β£315,645 into1,577,325 Ordinary Shares; 2. John Westcott and Mrs HF Westcott converted 51,000 Preference Shareswith a nominal paid up value of Β£68,048 into 340,240 Ordinary Shares; and 3. the trustees of the Westcott Family Trust converted 119,314 PreferenceShares with a nominal value of Β£159,892 into 799,460 Ordinary Shares. Accordingly, David Harding is now non-beneficially interested in 4,067,461Ordinary Shares representing 26.94per cent. of the Company's current issuedOrdinary Share capital (prior to the compulsory conversion process). In addition, John Westcott is now beneficially interested in 287,088 OrdinaryShares representing 1.90 per cent. of the Company's current issued OrdinaryShare capital (prior to the compulsory conversion process) and non-beneficiallyinterested in 4,067,461Ordinary Shares representing 26.94 per cent. of theCompany's current issued Ordinary Share capital (prior to the compulsoryconversion process). Finally, the Westcott Family Trust now holds 2,991,369 Ordinary Sharesrepresenting 19.81per cent. of the Company's current issued Ordinary Sharecapital (prior to the compulsory conversion process). 2 March 2007 Enquiries: Charles Stanley Securities 020 7149 6457 Philip Davies This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
27th Apr 20202:00 pmRNSPrice Monitoring Extension
27th Apr 202011:05 amRNSSecond Price Monitoring Extn
27th Apr 202011:00 amRNSPrice Monitoring Extension
24th Apr 20207:00 amRNSGrant of Options
20th Apr 20207:00 amRNSBleepa rolled out at PAH NHS Trust for Covid-19
26th Mar 20203:52 pmRNSFeedback Medical to offer Bleepa for COVID-19
18th Feb 20207:00 amRNSInterim Results
3rd Feb 202012:21 pmRNSAppointment of Non-Executive Director
21st Jan 202010:30 amRNSChange of Registered Office
13th Jan 20207:00 amRNSLicence agreement with Imaging Engineering
19th Nov 20197:00 amRNSResult of AGM
18th Nov 20197:01 amRNSAGM Statement
18th Nov 20197:00 amRNSFirst Bleepa pilot study initiated with NHS Trust
24th Oct 20198:28 amRNSFinal Results: Revenue up 23%
17th Oct 20197:00 amRNSUpdate re Bleepa®
27th Sep 20192:52 pmRNSStatement re share price
4th Sep 20197:00 amRNSBleepa - the clinical messaging app - at NHS Expo
3rd Sep 20199:46 amRNSHolding(s) in Company
2nd Sep 201912:24 pmRNSHolding(s) in Company
2nd Sep 20197:00 amRNSHolding(s) in Company
30th Aug 20195:00 pmRNSTotal Voting Rights
29th Aug 20192:06 pmRNSResult of General Meeting
29th Aug 20197:00 amRNSBoard Changes
13th Aug 20192:45 pmRNSPosting of Circular and Notice of General Meeting
12th Aug 20197:00 amRNSProposed placing and subscription to raise £2m
7th Aug 201910:47 amRNSStatement re Online Commentary
26th Jul 201912:03 pmRNSBleepa - revolutionising clinical messaging
10th Jul 20197:00 amRNSOutcome of strategic review and trading update
10th Jun 20199:28 amRNSHolding(s) in Company
7th Jun 201910:07 amRNSHolding(s) in Company
25th Apr 20197:00 amRNSTrading update
9th Apr 20197:00 amRNSFeedback Medical CEO appointed Feedback plc CEO
14th Feb 20197:00 amRNSFeedback Medical appoints Dr Tom Oakley as CEO
24th Jan 20197:00 amRNSHalf-year Results
23rd Jan 20192:02 pmRNSResult of AGM
30th Nov 20185:00 pmRNSTotal Voting Rights
29th Nov 20182:37 pmRNSFinal Results
22nd Nov 201812:59 pmRNSFeedback retains industry standard certification
19th Nov 20182:56 pmRNSDirector/PDMR Shareholding
19th Nov 201811:49 amRNSHolding(s) in Company
16th Nov 20189:16 amRNSHolding(s) in Company
15th Nov 201811:35 amRNSResult of General Meeting
1st Nov 20183:11 pmRNSHolding(s) in Company
31st Oct 20185:00 pmRNSTotal Voting Rights
31st Oct 20184:15 pmRNSHolding(s) in Company
29th Oct 20182:44 pmRNSNotice of General Meeting
25th Oct 20187:00 amRNSProposed placing and subscription to raise £1.375m
22nd Oct 20187:00 amRNSExpansion of European customer base
3rd Oct 20187:00 amRNSTrading update
1st Oct 20187:00 amRNSAppointment of Joint Broker

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.